HealthEquity, Inc. (NASDAQ:HQY) Receives Average Rating of “Buy” from Analysts

Shares of HealthEquity, Inc. (NASDAQ:HQY) have earned a consensus rating of “Buy” from the twelve brokerages that are currently covering the stock, Marketbeat.com reports. Twelve research analysts have rated the stock with a buy recommendation. The average 12 month price target among brokers that have issued a report on the stock in the last year is $103.83.

Several equities research analysts have commented on the stock. Barrington Research reiterated an “outperform” rating and issued a $105.00 price target on shares of HealthEquity in a research report on Friday, September 20th. Deutsche Bank Aktiengesellschaft boosted their price target on shares of HealthEquity from $102.00 to $103.00 and gave the stock a “buy” rating in a research report on Wednesday, September 4th. Royal Bank of Canada reiterated an “outperform” rating and issued a $92.00 price target on shares of HealthEquity in a research report on Wednesday, September 4th. JMP Securities reiterated a “market outperform” rating and issued a $105.00 price target on shares of HealthEquity in a research report on Wednesday, September 4th. Finally, Bank of America dropped their price target on shares of HealthEquity from $105.00 to $100.00 and set a “buy” rating on the stock in a research report on Wednesday, September 4th.

HealthEquity Stock Performance

HQY stock opened at $88.07 on Tuesday. The company has a market capitalization of $7.69 billion, a P/E ratio of 73.39, a PEG ratio of 1.37 and a beta of 0.52. The company has a 50-day simple moving average of $80.31 and a 200 day simple moving average of $79.75. HealthEquity has a fifty-two week low of $61.81 and a fifty-two week high of $89.23. The company has a quick ratio of 4.10, a current ratio of 4.10 and a debt-to-equity ratio of 0.51.

HealthEquity (NASDAQ:HQY) last posted its quarterly earnings data on Tuesday, September 3rd. The company reported $0.66 earnings per share for the quarter, topping the consensus estimate of $0.50 by $0.16. The business had revenue of $299.93 million during the quarter, compared to the consensus estimate of $284.48 million. HealthEquity had a net margin of 9.61% and a return on equity of 9.01%. Sell-side analysts predict that HealthEquity will post 2.27 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other HealthEquity news, Director Robert W. Selander sold 8,250 shares of HealthEquity stock in a transaction dated Wednesday, October 9th. The stock was sold at an average price of $82.98, for a total transaction of $684,585.00. Following the transaction, the director now owns 54,719 shares of the company’s stock, valued at $4,540,582.62. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. In other HealthEquity news, Director Robert W. Selander sold 8,250 shares of HealthEquity stock in a transaction dated Wednesday, October 9th. The stock was sold at an average price of $82.98, for a total transaction of $684,585.00. Following the transaction, the director now owns 54,719 shares of the company’s stock, valued at $4,540,582.62. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Frank Corvino sold 1,247 shares of HealthEquity stock in a transaction dated Tuesday, October 1st. The shares were sold at an average price of $80.26, for a total value of $100,084.22. Following the transaction, the director now directly owns 4,823 shares in the company, valued at approximately $387,093.98. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 2.20% of the company’s stock.

Hedge Funds Weigh In On HealthEquity

Several institutional investors and hedge funds have recently bought and sold shares of HQY. Vanguard Group Inc. grew its stake in shares of HealthEquity by 1.7% in the 1st quarter. Vanguard Group Inc. now owns 8,768,632 shares of the company’s stock valued at $715,783,000 after buying an additional 149,133 shares in the last quarter. Diversify Advisory Services LLC bought a new stake in shares of HealthEquity in the 1st quarter valued at approximately $7,828,000. Vaughan Nelson Investment Management L.P. bought a new stake in shares of HealthEquity in the 1st quarter valued at approximately $49,443,000. Lisanti Capital Growth LLC bought a new stake in shares of HealthEquity in the 1st quarter valued at approximately $4,701,000. Finally, Sei Investments Co. grew its stake in shares of HealthEquity by 2.3% in the 1st quarter. Sei Investments Co. now owns 570,051 shares of the company’s stock valued at $46,533,000 after buying an additional 12,958 shares in the last quarter. Hedge funds and other institutional investors own 99.55% of the company’s stock.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.